Login
InspireMD, Inc. logo

InspireMD, Inc.

inspiremd.com

What Do They Do?

Sells mesh-covered carotid stents for carotid artery disease to medical-product distributors and to U.S. interventional and surgical specialists.

How Do They Make Money?

Distributors and medical centers pay for products when they ship or are delivered, depending on the contract’s shipping terms.

FY2025 revenue

Who Are Their Customers?

Outside the United States, medical-product distributors buy CGuard EPS and handle local sales and marketing. In the United States, a direct sales organization serves interventional and surgical specialists.

Customers above 10% of revenue, FY2025
of revenue from two customers (14%, 12%)
FY2024: 33% from three customers

Do Revenues Turn Into Profits?

No. It lost $48.8M in FY2025.

Operating income, FY2025
−553% of revenue
▼ −48% (Loss) vs FY2024 (−$33.5M, −478%)
Net income, FY2025
−543% of revenue
▼ −52% (Loss) vs FY2024 (−$32M, −457%)
Free cash flow, FY2025
−409% of revenue
▼ −58% (Loss) vs FY2024 (−$23.3M, −332%)

How Are They Changing?

Since the FY2025 annual report
Latest quarter: Q2 FY2026, the three months to Jun 30, 2026
Revenue
▼ 0%
vs $1.8M in Q2 FY2025
Net income
▼ −9% (Loss)
vs −$13.2M in Q2 FY2025
  • Nov 12, 2026 FDA approves CGuard Prime for TCAR procedures The system can be used with an embolic protection system specified in the labeling.

Growing. Revenue grew 100% in 4 years, from $4.5M in FY2021 to $9M in FY2025, about 19% a year.

U.S. CGuard Prime sales The older report described CGuard Prime as a product in development and subject to regulatory approval; the latest says it is FDA-approved and sold in the United States through a direct salesforce.

Broader patient group The older report framed CGuard EPS around symptomatic high-grade carotid narrowing; the latest describes its addressable group as symptomatic and asymptomatic patients eligible for carotid stenting, TCAR, or surgery.

Who Do They Compete With?

Competes with Abbott Laboratories, Boston Scientific, Medtronic, Cordis, and Terumo Medical

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support